Skip to main content
BOLT
NASDAQ Life Sciences

10% Owner Coastlands Buys $319K of Bolt Biotherapeutics Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$6.21
Mkt Cap
$11.963M
52W Low
$3.1
52W High
$7.78
52W Position info
100% above low
Off High info
20% below high
Rel. Volume
Market data snapshot near publication time

BOLT has more than doubled off its 52-week low of $3.1.

Summary

Coastlands Capital LP, a 10% owner of Bolt Biotherapeutics, bought 50,000 shares at a weighted-average $6.38 for about $319,000, lifting its stake to 462,416 shares.


Key Events · Ownership and Investor Activity · BOLT

  • 10% Owner Buys $319K of Stock

    On 2026-11-09, Coastlands Capital LP purchased 50,000 shares at a weighted-average $6.38, for a total of $319,000.

  • Stake Rises to 462,416 Shares

    Post-transaction indirect holdings via Coastlands Capital LP stand at 462,416 shares.

  • Follows $120M Prana Deal

    The buy follows Bolt's announced acquisition of Prana Therapies and concurrent $120 million private placement, disclosed 2026-10-23.

  • Against Net Insider Selling

    Over the prior 90 days insiders were net sellers of about $123,839, mostly tax-withholding sales, making this open-market buy a counter-trend move.


Analysis · BOLT · Life Sciences

Coastlands Capital LP, a 10% owner, put $319,000 of real money into BOLT at a weighted-average $6.38 per share — an open-market purchase, not an option exercise or grant. For a company this small, that is a meaningful bet, and it lands just weeks after Bolt announced its Prana Therapies acquisition and $120 million private placement, a deal management says is needed to push PRA-216 forward. Because the buyer is a financial investor adding to a position rather than an operator, the signal carries less weight than a CEO buy would — but it is still the largest insider open-market buy in the recent record, against a 90-day backdrop of net insider selling.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BOLT was trading at $6.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12M. The 52-week trading range was $3.10 to $7.78. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BOLT - Latest Insights

BOLT
Oct 23, 2026, 9:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.19
Real-time Price: $6.56 info
Change: +$2.37 (+57%) info
Market Cap: $12.637M info
BOLT
Oct 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.51
Real-time Price: $6.56 info
Change: +$3.05 (+87%) info
Market Cap: $12.637M info
BOLT
Aug 11, 2026, 4:24 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $6.56 info
Change: +$2.58 (+65%) info
Market Cap: $12.637M info
BOLT
Aug 11, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.98
Real-time Price: $6.56 info
Change: +$2.58 (+65%) info
Market Cap: $12.637M info
BOLT
Aug 11, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $6.56 info
Change: +$2.58 (+65%) info
Market Cap: $12.637M info